ARS Pharmaceuticals (SPRY) Free Cash Flow Growth (5y) (2025 - 2026)

ARS Pharmaceuticals (SPRY) Free Cash Flow Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,200.25 Bn	66,199.96 Bn	-
2	Nanobiotix	1,908.00 Bn	1,907.94 Bn	-
3	Akari Therapeutics	959.56 Bn	959.56 Bn	-
4	BeOne Medicines	471.75 Bn	466.96 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.94 Bn	114.69 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	69.87 Bn	61.12 Bn	3.31 Bn
7	Belite Bio	62.43 Bn	62.43 Bn	-
8	Argenx Se	55.86 Bn	50.68 Bn	1.41 Bn
9	Alnylam Pharmaceuticals	37.49 Bn	34.48 Bn	959.66 Mn
10	ARS Pharmaceuticals	567.98 Mn	367.01 Mn	-

Download Data